Skip to content

Adarx Pharmaceuticals

US · ADRX #2823 by market cap Listed 2026
12.79 -1.37 -9.68%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Earnings Flash (ADRX) ADARx Pharmaceuticals, Inc. Reports Q3 Revenue $2.2M, Vs. FactSet Est of $2.6M
    MT Newswires · 2026/11/13
  • Emerging siRNA developer ADARx (ADRX.US) has launched a $350 million IPO, with AbbVie subscribing to a 4.9% stake and committing up to $100 million.
    Zhitong Finance · 2026/9/22
  • A Quick Look at Today's Ratings for Adarx Pharmaceuticals(ADRX.US), With a Forecast Between $32 to $38
    Market Newswire · 2026/10/21

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:38 · For reference only, not investment advice and not tailored to your situation.

Adarx Pharmaceuticals discussion 0 comments

Add a comment